AAAAAA

   
Results: 1-17 |
Results: 17
ABCIXIMAB ASSOCIATED THROMBOCYTOPENIA - EVIDENCE FOR A COMPLEX INTERACTION WITH HEPARIN
Authors: KEREIAKES DJ BERKOWITZ SD ANDERSON K SIMOONS M VAHANIAN A LINCOFF AM TCHENG JE WEISMAN H CALIFF RM TOPOL EJ
Citation: Dj. Kereiakes et al., ABCIXIMAB ASSOCIATED THROMBOCYTOPENIA - EVIDENCE FOR A COMPLEX INTERACTION WITH HEPARIN, Journal of the American College of Cardiology, 31(2), 1998, pp. 55-55
INHIBITION OF PLATELET GLYCOPROTEIN IIB IIIA WITH EPTIFIBATIDE IN PATIENTS WITH ACUTE CORONARY SYNDROMES/
Authors: TOPOL E CALIFF R SIMOONS M DIAZ R PAOLASSO E KLEIN W BOLAND J DEBACKER G ARMSTRONG P CORBALAN R ISAZA D WIDIMSKY P URRUTIA C LUOMANMAKI K VAHANIAN A KARSCH K COKKINOS D KARATASAKIS G TOUTOUZAS P RODAS M KELTAI M CHIERCHIA S SILVA E ERIKSSEN J RUZYLLO W STEPINSKA J RIBEIRO VD FERNANDEZORTIZ A MACAYA C GOY J DECKERS J SKENE A WILCOX R GUERCI A HARRINGTON R HOCHMAN J HOLMES D KLEIMAN N KOPECKY S LEE K LINCOFF A OHMAN E PEPINE C ISEA J
Citation: E. Topol et al., INHIBITION OF PLATELET GLYCOPROTEIN IIB IIIA WITH EPTIFIBATIDE IN PATIENTS WITH ACUTE CORONARY SYNDROMES/, The New England journal of medicine, 339(7), 1998, pp. 436-443
A CLINICAL-TRIAL COMPARING PRIMARY CORONARY ANGIOPLASTY WITH TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION
Authors: BETRIU A PHILLIPS H ELLIS S TOPOL E CALIFF R VANDERWERF F ARDISSINO D ARMSTRONG PW AYLWARD P BATES E BEATT K CHESEBORO J COL J EMANUELSSON H FUSTER V GIBLER WB GORE J GUERCI A HOCHMAN J HOLMES D KLEIMAN D MORRIS D NEUHAUS K OHMAN M PFISTERER M RUTSCH W SIMES J SIMOONS M VAHANIAN A WEAVER WD WHITE H GRANGER C HOCHREIN J FRAULO B MOFFIE I PARASCHOS L STEBBINS A WOODLIEF L LEE K PIEPER K WAGNER GS GATES K DEBOWEY D POLISZCZUK R VILSACK H LUYREN A TOBBACK L KAVA M SUTHERLAND W FRYE R CHEITLIN M DEMETS D FISHER L HIRSH J SERRUYS P WALTERS L HANOVICH G ANTOLICK A KELLETT M BERG C JAMAL NM WHITING D KIRSHNASWAMI V HEYL A GOSSMAN D DORLAND M BERRIOS E SEXSON R IBARRA J FREY L LANCASTER L LANSMAN D SHERIDAN F MCRAE R HEJL S PALMERI S CASAZZA L SCHRADING W SONIN N TALLEY D TALLEY J ASHCRAFT S NILES N EDKINS R HOLLYWOOD L SYMKOVIAK G PINCOCK J MISHKEL D LEHMANN J LAWMCKENZIE R GAINEY PC BAKER D MADDOX W STURM C MILLER R WOODS S DAGEFORD D HANRAHAN J GILCHRIST I ZIMMERMAN H WILLIAMS M STEGALL G PERRY J SCHVANEVELDT W RIBA A DRAUS C OTOOLE JD SUDINA K SPRIGGS D SCHULZ F MADDOX WT ALLAN S HAMMER C WHITE C SMITH J HARRAH L SCHMIDT P NESS C KAPLAN J STEFFANS G GACIOCH G CHIODO V HANGER K CHAPUSEAUX C FERNANDEZ EG AVILES FF BOLAND J CASTADOT M LEGRAND V SCHROEDER E VASSANELLI C CERNIGLIARO C REPETTO S VALSECCHI O TOPP H RISENFORS M AMANN FW URBAN P DOLAN S NELSON G SCAMMELL R BETT N NEWITT C LABINZA M KEARNS S
Citation: A. Betriu et al., A CLINICAL-TRIAL COMPARING PRIMARY CORONARY ANGIOPLASTY WITH TISSUE-PLASMINOGEN ACTIVATOR FOR ACUTE MYOCARDIAL-INFARCTION, The New England journal of medicine, 336(23), 1997, pp. 1621-1628
PERSPECTIVES ON LARGE-SCALE CARDIOVASCULAR CLINICAL-TRIALS FOR THE NEW MILLENNIUM
Authors: TOPOL EJ CALIFF RM VANDEWERF F SIMOONS M HAMPTON J LEE KL WHITE H SIMES J ARMSTRONG PW
Citation: Ej. Topol et al., PERSPECTIVES ON LARGE-SCALE CARDIOVASCULAR CLINICAL-TRIALS FOR THE NEW MILLENNIUM, Circulation, 95(4), 1997, pp. 1072-1082
INCIDENCE AND PREDICTORS OF BLEEDING AFTER CONTEMPORARY THROMBOLYTIC THERAPY FOR MYOCARDIAL-INFARCTION
Authors: BERKOWITZ SD GRANGER CB PEIPER KS LEE KL GORE JM SIMOONS M ARMSTRONG PW TOPOL EJ CALIFF RM
Citation: Sd. Berkowitz et al., INCIDENCE AND PREDICTORS OF BLEEDING AFTER CONTEMPORARY THROMBOLYTIC THERAPY FOR MYOCARDIAL-INFARCTION, Circulation, 95(11), 1997, pp. 2508-2516
A COMPARISON OF RECOMBINANT HIRUDIN WITH HEPARIN FOR THE TREATMENT OFACUTE CORONARY SYNDROMES
Authors: TOPOL EJ CALIFF R GRANGER C VANDEWERF F AYLWARD P SIMES J COL J ARMSTRONG P VAHANIAN A NEUHAUS K RUTSCH W ARDISSINO D SIMOONS M WHITE H BETRIU A EMANUELSSON H PFISTERER M BEATT K BATES E CHESEBORO J ELLIS S FUSTER V GIBLER W GORE J GUERCI A HOCHMAN J HOLMES D KLEIMAN N MORRIS D OHMAN M PHILLIPS H WEAVER D LEE K WOODLEAF L MILLER G BAHR R WORLEY S SCHRADING W GILCHRIST I IBARRA J KRISHNASWAMI V NYGAARD T DAGEFORDE D PUMA J PALMERI S ROSING D DALE H BOYEK T MORRICE B WEINBERG S NOBLE W VANGILDER J OTOOLE J JESSE R LOSS D WERTHEIMER J FERRARI D SANTER M STRAHAN N SCHAEFFER J AVEINGTON M MILLER R EICH D VROBEL T KERIEAKES D SHARMA S BECKWITH W MICALE P POLINSKI W GOODFIELD P PARASCHOS A CHANDLER A TALLEY J MORSE H SHERIDAN F SILVERMAN M BAGA V WARE J SEAGLE R MADDOX W SCHRANK J GAINEY P MORRIS D IWAOKA R SCHNEIDER R INGRAM R HANGER K LANE G BEESON W WILLIAMS D BEASLEY C SPRIGGS D SCHLANT R SULLEBARGER J SMITH J MISHKEL D WILLIAMS C GIBBS K HEARON B GONZALES M SHEIKH K DEDONIS J LONG T POPIO K JAMAL N LAMBREW C LABIB S VORCHHEIMER D WEISS R MERCADANTE N GUEREI A RASHKOW A BALLELI L GACIOCH G NILES N SEIDENSTEIN H HOLLANDER G WALLACH R KHAN A GRAHAM S SIMONS A WARD H PARKES R WATKINS M DELUCCIA W URBACH D GRODMAN R MCCORD D BLEIBERG M CORBELLI J PEPE A ZWERNER P PINSKY L PETROVICH L LINDENBERG B THERRIEN M SANDS M ROSENFELD A SHEIKH S RIBA A HANOVICH G SWENSON L HOLLAND K SCHMIDT P BESLEY D HESSION W FERRIGNI F MEYERS D DUVERNOY W ABRAMOWITZ B STOMEL R BECKER J MOOSS A THOMPSON J CALLI L PENILLA A MCCRISKIN J MILLSAPS R HEINSIMER J PFEFFERKORN D SADDIN M FINTEL D HARNER R KOPECKY S ANDRES P COOK L WEFALD F VANDERLAAN R LOVE J ZANDS M SANTOLIN C ARNOLD A OATFIELD R JAEGER K DEAN E SWENSON R LANCASTER L RASKIN S FEHRENBACHER G LOMBARDO T STRUNK B PERRY J LAI P ROWE W SYMKOVIAK G LEE H KWEE H WOOLBERT S MILLER R KAPLAN J TITUS B WOLFE C CISLOWSKI D BERNDT T WHITE R BROWN D HILL D HUI G SPIEGEL R WESLEY G MATTERN A LAPIN E STERN M KRAUS M OLSON H SCOTT R MACKENZIE B HUI W ROTH S GOODE E BURTON J SENARATNE M TRABOULSI M GREENWOOD P MORGAN C ERVIN F MCDOWELL J LEFKOWITZ C SAUVE M TUREK M FINNIE K KURUVILLA G LANGE A CHARLES J KELLS C VIZEL S BAILLIE H SAHAY B ROTH D LUBELSKY B JABLONSKY G LESOWAY R KOWK K MACMILLAN C ADELMLAN A LABINAZ M GUAGLIUMI G BRANZI A GALVANI M MAFRICI A SAVONITTO S FORNARO G COLOMBI E ZANUTTINI D OTTANI F CAVALLINI C CAMERINI F REPETTO S VASSANELLI C ROVELLI E POLESE A POLITI A CAPUCCI A MAMBELLI M SABATE X MASIA R BESCOS LL SENDON JL JODAR L RODRIQUEZLLORIAN A MARTINLUENGO C SAENZ L FERNANDEZAVILES F FROUFE J LOMAOSORIO A BAYON J JEFFREY I NELSON G WALSH W LEITCH J CAMPBELL T HEALEY J OWENSBY D RAMSEY D GRIGG L FERDERMAN J NEWMAN R STRICKLAND J LIM P COUNSELL J CROSS D GARRAHY P COVERDALE S BETT N ARONCY G BROWN M SIMMONS G HOROWITZ J THOMPSON P HOCKINGS B HENDRICKS R THOMSON A RANKIN R BOUMA H COZYNSEN L STOLWIJK P DROST H VANKALMTHOUT P ENGBERS J WESTENDORP P VOORBURG J VEERHOEK M PAOHAN T BOGERIJEN L MISIER AR BOSKER H SMITS W TAN T CASTADOT M INSTALLE E DEMEESTER A BOLAND J LEGRAND V VANWELDEN J PIRENNE B EMMERECHTS C BEEUWSAERT R THIELS H BECKERS J LESSELIERS H POPEYE R QUIRET J MARONI J FARAH B ETIENNE Y FUNCK F THANK XT KHALIFE K LECLERCQ F VITOUX B COHEN A VACHERON A BARREAU D SIMON R KREFT H DITTER H ZEIHER A WEIZNER M WACKER R MARBACH M NAST H MEYERHOFMANN H SCHMITZHUBNER U BODE M MAISCH B TOPP H RUTSCH W LOLLGEN H WILLIAMS M DURHAM D BRUNS B HAYES D LESLIE P HART H IKRAM H MANN S KIRK A JARDINE D RANKIN R AUDEAU M ANANDARAJA S COOPER I HOGAN J HACKETT D TRAVILL C BRIDGON G BURRELL C DEBELDER M ROZKOVEC A KOONER J JAMES M GARCIA E RISENFORS M PFISTERER M BAUR H URBAN P MOCETTI T ANGEHRN W BERTEL O AMANN F
Citation: Ej. Topol et al., A COMPARISON OF RECOMBINANT HIRUDIN WITH HEPARIN FOR THE TREATMENT OFACUTE CORONARY SYNDROMES, The New England journal of medicine, 335(11), 1996, pp. 775-782
VECTORCARDIOGRAPHIC MONITORING TO ASSESS EARLY VESSEL PATENCY AFTER REPERFUSION THERAPY FOR ACUTE MYOCARDIAL-INFARCTION
Authors: DELLBORG M STEG PG SIMOONS M DIETZ R SEN S VANDENBRANDT M LOTZE U HAUCK S VANDENWIEKEN R HIMBERT D SVENSSON AM SWEDBERG K
Citation: M. Dellborg et al., VECTORCARDIOGRAPHIC MONITORING TO ASSESS EARLY VESSEL PATENCY AFTER REPERFUSION THERAPY FOR ACUTE MYOCARDIAL-INFARCTION, European heart journal, 16(1), 1995, pp. 21-29
PREDICTORS OF 30-DAY MORTALITY IN THE ERA OF REPERFUSION FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM AN INTERNATIONAL TRIAL OF 41 021 PATIENTS
Authors: LEE KL WOODLIEF LH TOPOL EJ WEAVER WD BETRIU A COL J SIMOONS M AYLWARD P VANDEWERF F CALIFF RM
Citation: Kl. Lee et al., PREDICTORS OF 30-DAY MORTALITY IN THE ERA OF REPERFUSION FOR ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM AN INTERNATIONAL TRIAL OF 41 021 PATIENTS, Circulation, 91(6), 1995, pp. 1659-1668
ADVANTAGES OF PATIENT-SPECIFIC PREDICTIONS OVER SUBGROUP ANALYSIS IN DEFINING DIFFERENTIAL TREATMENT EFFECTS OF TPA AND STREPTOKINASE FROM THE GUSTO TRIAL
Authors: CALIFF RM SIMOONS M LEE KL HARRELL FE TOPOL EJ
Citation: Rm. Califf et al., ADVANTAGES OF PATIENT-SPECIFIC PREDICTIONS OVER SUBGROUP ANALYSIS IN DEFINING DIFFERENTIAL TREATMENT EFFECTS OF TPA AND STREPTOKINASE FROM THE GUSTO TRIAL, Journal of the American College of Cardiology, 1994, pp. 10000027-10000027
EFFECT OF SIMVASTATIN ON CORONARY ATHEROMA - THE MULTICENTER ANTI-ATHEROMA STUDY (MAAS)
Authors: OLIVER MF DEFEYTER PJ LUBSEN J POCOCK S SIMOONS M BACHMANN K DELAYE J EMANUELSSON H KALTENBACH M KINGMA JH LEGRAND V RAFFLENBEUL W RUTSCH W SIMOONS ML STOEL I THOMPSON GR SAELMAN JPM DECKERS JW QUERE M SIX AJ VERMEERS PHMJ SELIN K WIKLUND O DAVIES G MAHER V REYNEN K MARTINEZ C SCHMUTZLER H BOTT J SCHNEIDER W WINKELMANN BR TENKATE J NIKUTTA P DELAY J MATHIEUMULIN MP VOS J BOERMA GJM MEYER J VOGEL RA AMO D PAMEIJER J RODENBURG L SEED P DUMONT JM JONKERS P SUCKOW XF VANDALEN FJ
Citation: Mf. Oliver et al., EFFECT OF SIMVASTATIN ON CORONARY ATHEROMA - THE MULTICENTER ANTI-ATHEROMA STUDY (MAAS), Lancet, 344(8923), 1994, pp. 633-638
EFEGATRAN, A NEW DIRECT THROMBIN INHIBITOR - SAFETY AND DOSE-RESPONSEIN PATIENTS WITH UNSTABLE ANGINA
Authors: SIMOONS M LENDERINK T SCHEFFER M STOEL I DEMILLIANO P REMME W WERNER H LEENDERS C MOLHOEK G ARNOLD A STIBBE J ROBERTS E
Citation: M. Simoons et al., EFEGATRAN, A NEW DIRECT THROMBIN INHIBITOR - SAFETY AND DOSE-RESPONSEIN PATIENTS WITH UNSTABLE ANGINA, Circulation, 90(4), 1994, pp. 231-231
EFEGATRAN, A NEW DIRECT THROMBIN INHIBITOR - SAFETY AND DOSE-RESPONSEIN PATIENTS WITH UNSTABLE ANGINA
Authors: SIMOONS M LENDERINK T SCHEFFER M STOEL I DEMILLIANO P REMME W WERNER H LEENDERS C MOLHOEK G ARNOLD A STIBBE J ROBERTS E
Citation: M. Simoons et al., EFEGATRAN, A NEW DIRECT THROMBIN INHIBITOR - SAFETY AND DOSE-RESPONSEIN PATIENTS WITH UNSTABLE ANGINA, Circulation, 90(4), 1994, pp. 231-231
RANDOMIZED TRIAL OF INTRAVENOUS HEPARIN VERSUS RECOMBINANT HIRUDIN FOR ACUTE CORONARY SYNDROMES
Authors: TOPOL E CALIFF R VANDEWERF F ARDISSINO D ARMSTRONG P AYLWARD P BARBASH G BATES E BEATT K BETRIU A CHESEBRO J COL J ELLIS S EMANUELSSON H FUSTER V GIBLER W GORE J GUERCI A HOCHMAN J HOLMES D KLEIMAN N MORRIS D NEUHAUS K OHMAN M PFISTERER M PHILLIPS H RUTSCH W SIMES J SIMOONS M VAHANIAN A WEAVER D WHITE H
Citation: E. Topol et al., RANDOMIZED TRIAL OF INTRAVENOUS HEPARIN VERSUS RECOMBINANT HIRUDIN FOR ACUTE CORONARY SYNDROMES, Circulation, 90(4), 1994, pp. 1631-1637
AN INTERNATIONAL RANDOMIZED TRIAL COMPARING 4 THROMBOLYTIC STRATEGIESFOR ACUTE MYOCARDIAL-INFARCTION
Authors: TOPOL E CALIFF R VANDEWERF F ARMSTRONG PW AYLWARD P BARBASH G BATES E BETRIU A BOISSEL JP CHESEBRO J COL J DEBONO D GORE J GUERCI A HAMPTON J HIRSH J HOLMES D HORGAN J KLEIMAN N MARDER V MORRIS D OHMAN M PFISTERER M ROSS A RUTSCH W SADOWSKI Z SIMOONS M VAHANIAN A WEAVER WD WHITE H WILCOX R
Citation: E. Topol et al., AN INTERNATIONAL RANDOMIZED TRIAL COMPARING 4 THROMBOLYTIC STRATEGIESFOR ACUTE MYOCARDIAL-INFARCTION, The New England journal of medicine, 329(10), 1993, pp. 673-682
TRANSIENT EXACERBATION OF ST-SEGMENT ELEVATION UPON REPERFUSION IN ACUTE MYOCARDIAL-INFARCTION
Authors: STEG PG DELLBORG M SIMOONS M
Citation: Pg. Steg et al., TRANSIENT EXACERBATION OF ST-SEGMENT ELEVATION UPON REPERFUSION IN ACUTE MYOCARDIAL-INFARCTION, Journal of electrocardiology, 26, 1993, pp. 156-156
INCREASED RATE OF EVOLUTION OF QRS CHANGES IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM THE VERMUT STUDY
Authors: DELLBORG M STEG PG SIMOONS M DIETZ R SEN S VANDENBRAND M LOTZE U HAUCK S JULIARD JM SWEDBERG K
Citation: M. Dellborg et al., INCREASED RATE OF EVOLUTION OF QRS CHANGES IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - RESULTS FROM THE VERMUT STUDY, Journal of electrocardiology, 26, 1993, pp. 244-248
MORTALITY REDUCTION WITH ACCELERATED TISSUE-PLASMINOGEN ACTIVATOR IS EXPLAINED BY EARLY CORONARY PATENCY
Authors: SIMES J ROSS AM SIMOONS M VANDERWERF F TOPOL EJ
Citation: J. Simes et al., MORTALITY REDUCTION WITH ACCELERATED TISSUE-PLASMINOGEN ACTIVATOR IS EXPLAINED BY EARLY CORONARY PATENCY, Circulation, 88(4), 1993, pp. 291-291
Risultati: 1-17 |